pensyarah perubatan
jabatan obstetrik & ginekologi
nirmala@ukm.edu.my
Associate Prof Dr Nirmala Chandralega Kampan is a Consultant in O&G and a Gyaneoncologist. She did her undergraduate medical studies in Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur. Following her internship in Ministry of Health hospitals, she joined Universiti Kebangsaan Malaysia’s Department of Obstetrics & Gynaecology in 2004 as a Trainee Lecturer. While working in UKM, she received a two-year Double Sponsorship Award, allowing her to work in the United Kingdom and pursue MRCOG examination, which was successfully accomplished in 2008. She then went on to complete her Masters in O&G in UKM a year later, and thereafter served in UKM as a Lecturer. She also successful completed a Fellowship in Minimally Invasive Surgery in Gynaecology. Her various role encompasses undergraduate and postgraduate student’s teaching, while also being actively involved in clinical services and research activities. She has successfully published up to 50 articles concerning women’s health in various medical journal, magazines and books. Having seen how poor the outcomes were for women diagnosed with ovarian cancer in Malaysia, Dr Nirmala decided to pursue her clinical fellowship training in gynae-oncology at Royal Women Hospital, Melbourne Australia, followed by PhD in Medicine at Monash University, Australia. Returning back to UKM in 2017, she is passionate about optimising the gynaecology services both clinically and in terms of research in order to provide the best outcomes for our women.
nirmala @ chandralega a/p kampan;mohamad nasir bin shafiee;nor haslinda binti abd aziz;p. susthitha menon a/p n v visvanathan;chew kah teik. (2024). developing a multi-biomarker signature panel for diagnosis of epithelial ovarian cancer using surface plasmon resonance (spr) technology and validation with multiplex immunobead assay and single cell sequencing.. - . .
bo seong yun, kwang-beom lee, keun ho lee, ha kyun chang, joo-young kim, myong cheol lim, chel hun choi, hanbyoul cho, dae-yeon kim, yun hwan kim, joong sub choi, chae hyeong lee,...nirmala kampan.... (2024). therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer iiicr: a trial protocol for a phase iii, multicenter, randomized controlled study (kgog1047/debulk trial). - journal of gynecologic oncology. 1-11.
tan geok chin;salwati binti shuib;nirmala @ chandralega a/p kampan;nor haslinda binti abd aziz;wong yin ping. (2023). characterisation of the expression of paternal and maternal imprinted related genes in hydatidiform mole. - . .
nirmala @ chandralega a/p kampan;mohd hashim bin omar;norfilza mohd mokhtar;mohamad nasir bin shafiee;nor haslinda binti abd aziz;chew kah teik;reena rahayu md zin. (2023). detection of inflammatory and immunosuppressive molecular alteration signatures to prevent disease relapse in women with high-grade serous ovarian cancer. . - . .
nirmala @ chandralega a/p kampan;muhammad azrai bin abu. (2023). a retrospective study on patients with non- obstructive azoospermia (noa) undergoing testicular sperm extraction (tese) and predictive factors for successful sperm retrieval among patients attending infertility unit.. - . .
bo seong yun, kwang-beom lee, keun ho lee, ha kyun chang, joo-young kim, myong cheol lim, chel hun choi, hanbyoul cho, dae-yeon kim, yun hwan kim, joong sub choi, chae hyeong lee,...nirmala kampan.... (2024). therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer iiicr: a trial protocol for a phase iii, multicenter, randomized controlled study (kgog1047/debulk trial). - journal of gynecologic oncology. 1-11.
mohd nazzary mamat @ yusof, kah teik chew, abdul muzhill hannaan abdul hafizz, siti hajar abd azman, wira sorfan ab razak , muhammad rafiuddin hamizan , nirmala chandralega kampan and mohamad nasir shafiee. (2023). efficacy and safety of pd-1/pd-l1 inhibitor as single-agent immunotherapy in endometrial cancer: a systematic review and meta-analysis. - cancers. 1-18.
mohd nazzary mamat @ yusof, kah teik chew, nirmala chandralega kampan and mohamad nasir shafiee. (2023). expression of pd-1 and pd-l1 in endometrial cancer: molecular and clinical significance. - international journal of molecular sciences. 1-17.
nirmala chandralega kampan, april kartikasari, cyril deceneuux, mutsa tatenda madondo, orla m. mcnally, katie louise flanagan, norhaslinda a. aziz, andrew n. stephens, john reynolds, michael a. quinn, magdalena plebanski.. (2023). combining tnfr2-expressing tregs and il-6 as superior diagnostic biomarkers for high-grade serous ovarian cancer masses. - cancers. 1-20.
vikneswary ravi kumar, nirmala chandralega kampan, nor haslinda abd aziz, chew kah teik, mohamad nasir shafiee and p. susthitha menon. (2023). recent advances in surface plasmon resonance (spr) technology for detecting ovarian cancer biomarkers. - cancers. 5607-5633.
chew kah teik, nirmala kampan, mohamad nasir shafiee. (2020). recurrence of ovarian cancer with distant metastasis after five years: a single institute experience. - international journal of gynecological cancer. A74-A75.
abdul muzhill hannaan abdul hafizz , reena rahayu md zin , nor haslinda abd aziz , nirmala chandralega kampan, mohamad nasir shafiee. (2020). beyond lipid-lowering: role of statins in endometrial cancer. - molecular biology reports. 8199-8207.
n kampan, j silva raju, kt chew, mf mohd saleh, rr md zin, r jeganathan, mn shafieeand n abd aziz. (2020). the protein expression of tnfr2 and stat3 in high-grade serous ovarian cancer (hgsc) tissue and its association with platinum sensitivity. - international journal of gynecological cancer. A47.
loh sweet yi esther, kah teik chew, rahana abd rahman, ani amelia zainuddin, erica yee hing and nirmala kampan. (2020). uterine-conserving approach in ruptured intramyometrial ectopic pregnancy. - hormone molecular biology and clinical investigations. 100-101.
aida kalok, pravin peraba,shamsul azhar shah, zaleha abdullah mahdy, mohamad abdul jamil, nirmala kampan, suraya sulaiman, nor azlin mohamed ismail. (2018). screening for gestational diabetes in low-risk women: effect of maternal age. - hormone molecular biology and clinical investigation. .
bo seong yun, kwang-beom lee, keun ho lee, ha kyun chang, joo-young kim, myong cheol lim, chel hun choi, hanbyoul cho, dae-yeon kim, yun hwan kim, joong sub choi, chae hyeong lee,...nirmala kampan.... (2024). therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer iiicr: a trial protocol for a phase iii, multicenter, randomized controlled study (kgog1047/debulk trial). - journal of gynecologic oncology. 1-11.
mohd nazzary mamat @ yusof, kah teik chew, abdul muzhill hannaan abdul hafizz, siti hajar abd azman, wira sorfan ab razak , muhammad rafiuddin hamizan , nirmala chandralega kampan and mohamad nasir shafiee. (2023). efficacy and safety of pd-1/pd-l1 inhibitor as single-agent immunotherapy in endometrial cancer: a systematic review and meta-analysis. - cancers. 1-18.
vikneswary ravi kumar, nirmala chandralega kampan, nor haslinda abd aziz, chew kah teik, mohamad nasir shafiee and p. susthitha menon. (2023). recent advances in surface plasmon resonance (spr) technology for detecting ovarian cancer biomarkers. - cancers. 5607-5633.
mohd nazzary mamat @ yusof, kah teik chew, nirmala chandralega kampan, nor haslinda abd. aziz, abdul muzhill hannaan abdul hafizz, mohamad nasir shafiee. (2023). gene expression of immune-related markers, pd-1, pd-l1, and pd-l2 in tissue of endometrioid endometrial cancer. - the medical journal of malaysia. 73.
nirmala chandralega kampan, april kartikasari, cyril deceneuux, mutsa tatenda madondo, orla m. mcnally, katie louise flanagan, norhaslinda a. aziz, andrew n. stephens, john reynolds, michael a. quinn, magdalena plebanski.. (2023). combining tnfr2-expressing tregs and il-6 as superior diagnostic biomarkers for high-grade serous ovarian cancer masses. - cancers. 1-20.
p susthitha menon, nur shahirah shaári, vatsala pithaih, siti nasuha mustaffa, affa rozana abdul rashid, vikneswary ravi kumar, nor haslinda abd aziz, nirmala kampan. (2023). graphene-based hybrid sensor for the detection of cancer cells using k-spr technology. - 2023 ieee regional symposium on micro and nanoelectronics (rsm). 58-61.
nirmala chandralega kampan, mutsa tatenda madondo, orla m. mcnally, andrew n. stephens, michael a. quinn and magdalena plebanski. (2019). interleukin 6 present in inflammatory ascites from advanced epithelial ovarian cancer patients promotes tumor necrosis factor receptor 2-expressing regulatory t cells. - the role of tnf-tnfr2 signal in immunosuppressive cells and its therapeutic implications. 24-37.
muhammad azrai abu,nirmala kampan, rahana abdul rahman, shareenaishak, wan nurul huda wan md zin. (2019). labour ward companion. - . 9.
mohammad nasir shafiee, nirmala kampan, rahaya bustamam. (2019). labour ward companion. - . 234.
nirmala chandralega kampan, chew kah teik, mohamed nasir shafiee, abdul kadir abdul karim, lim pei shan, nor azlin mohamed ismail, nur azurah abd ghani. (2022). the covid-19 pandemic: the experiences of hospital canselor tuanku muhriz (hctm). - . 9.
mohammad nasir shafiee, nirmala kampan, rahaya bustamam. (2019). labour ward companion. - . 234.
muhammad azrai abu,nirmala kampan, rahana abdul rahman, shareenaishak, wan nurul huda wan md zin. (2019). labour ward companion. - . 9.
nirmala kampan, che hasnura, mohd azrai abu, khairun niza, lim pei shan, nur azurah abd ghani. (2016). an essential guide to - basic gynae-laparoscopy. - . 9-34.
nirmala kampan, lim pei shan, mohd hashim omar. (2016). an essential guide to - basic gynae-laparoscopy. - . 1-2.
nirmala chandralega kampan & chew kah teik. (2016). an essential guide to - basic gynae-laparoscopy. - . 102.
ma jamil,zaleha a mahdy,nor azlin mi,harlina halizah,shuhaila a,norzilawati mn,tan ay,ani amelia z,yh lim,ps lim,natasha mn,ixora ka,chris cy lee,rohana j,nirmala ck,shafiee mn,fadzila mp,fauziah ah,n. (2008). handbook of labour room practice: a comprehensive guide to the management of women in labour. - . 296.
nirmala @ chandralega a/p kampan;mohamad nasir bin shafiee;nor haslinda binti abd aziz;p. susthitha menon a/p n v visvanathan;chew kah teik. (2024). developing a multi-biomarker signature panel for diagnosis of epithelial ovarian cancer using surface plasmon resonance (spr) technology and validation with multiplex immunobead assay and single cell sequencing.. - . .
dayang anita binti abdul aziz;zarina binti abdul latiff;roszalina bt. ramli;ani amelia binti zainuddin;hamidah binti alias;nirmala @ chandralega a/p kampan;nur azurah binti abdul ghani;farrah hani binti imran;doris lau sie chong;soon bee hong;loh c-khai;z. (2023). outcomes of surgery in covid-19 infection: international cohort study (covidsurg). - . .
tan geok chin;salwati binti shuib;nirmala @ chandralega a/p kampan;nor haslinda binti abd aziz;wong yin ping. (2023). characterisation of the expression of paternal and maternal imprinted related genes in hydatidiform mole. - . .
nirmala @ chandralega a/p kampan;muhammad azrai bin abu. (2023). a retrospective study on patients with non- obstructive azoospermia (noa) undergoing testicular sperm extraction (tese) and predictive factors for successful sperm retrieval among patients attending infertility unit.. - . .
nirmala @ chandralega a/p kampan;mohd hashim bin omar;norfilza mohd mokhtar;mohamad nasir bin shafiee;nor haslinda binti abd aziz;chew kah teik;reena rahayu md zin. (2023). detection of inflammatory and immunosuppressive molecular alteration signatures to prevent disease relapse in women with high-grade serous ovarian cancer. . - . .
Geran / Grant | Kolaborator / Collaborator | Status |
---|---|---|
A COMPARISON OF SENTINEL LYMPH NODE BIOPSY TO LYMPHADENECTOMY FOR ENDOMETRIAL CANCER STAGING | ummi surgical sdn. bhd. | 46.8% (2023-07-31 sehingga 2026-07-30) |
ELUCIDATING THE ROLE OF IGF-1 ISOFORMS IN ENDOMETRIOID ENDOMETRIAL CANCER MICROENVIRONMENT AND ITS ASSOCIATION WITH CLINICAL OUTCOMES | university of nottingham, united kingdom | 94.4% (2021-09-07 sehingga 2025-03-06) |
URINE HPV TESTING FOR CERVICAL CANCER SCREENING AMONG MALAYSIAN WOMEN- FEASIBILITY AND ACCURACY | fjord diagnostics sdn bhd | 97.7% (2023-01-12 sehingga 2025-01-11) |